{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-002805","form_type":"8-K","ticker":"CAH","cik":"0000721371","company_name":"CARDINAL HEALTH INC","filed_at":"2024-02-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.752514+00:00","generated_at":"2026-06-06T12:10:25.344491+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Cardinal Health Q2 revenue up 12% to $57.4B; non-GAAP EPS $1.82 (+38%); FY24 guidance raised","bullets":["GAAP diluted EPS $1.43 vs. $(0.50) prior year; non-GAAP operating earnings $562M, up 20%.","Pharmaceutical segment profit $518M (+12%); Medical segment profit $71M vs. $17M.","FY24 non-GAAP EPS guidance raised to $7.20-$7.35 from $6.75-$7.00; adj. free cash flow ~$2.5B.","Announced acquisition of Specialty Networks, a tech-enabled multi-specialty GPO and practice enhancement organization.","Revenue $57.4B, driven by brand/specialty pharmaceutical sales growth and COVID-19 vaccine distribution."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-002805","json":"https://secwatch.observer/filing/0001628280-24-002805.json","markdown":"https://secwatch.observer/filing/0001628280-24-002805.md","text":"https://secwatch.observer/filing/0001628280-24-002805.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/721371/000162828024002805/0001628280-24-002805-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/721371/000162828024002805/cah-20240201.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T12:10:25.344491+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"81ee69167003d8a76a97731f58edcfb9ae8520b6","claim":"CARDINAL HEALTH INC reported the quarter ended December 31, 2023 results: revenue $57.4 billion, EPS $1.43. Guidance raised.","evidence_excerpt":"report. --- EX-99.1 (EX-99.1) --- FOR IMMEDIATE RELEASE Cardinal Health Reports Second Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook • Revenue increased 12% to $57.4 billion • GAAP 1 operating earnings were $482 million; GAAP diluted EPS was $1.43 • Non-GAAP operating earnings increased 20% to $562 million; non-GAAP diluted EPS increased 38% to $1.82","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/721371/000162828024002805/0001628280-24-002805-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended December 31, 2023"},{"label":"Revenue","value":"$57.4 billion"},{"label":"EPS","value":"$1.43"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}